Cargando…
Predictors of treatment outcomes following treat-and-extend regimen with aflibercept for branch retinal vein occlusion: post-hoc analysis of the PLATON trial
We investigated predictors of visual outcomes and injection interval in macular edema (ME) secondary to branch retinal vein occlusion (BRVO) treated with a treat-and-extend (TAE) regimen. All 48 patients in a multicenter study were followed for 52 weeks and received three monthly intravitreal aflibe...
Autores principales: | Son, Wonyung, Jeong, Woo Jin, Park, Jung Min, Kim, Jung-Yeul, Ji, Yong-Sok, Sagong, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359445/ https://www.ncbi.nlm.nih.gov/pubmed/37474669 http://dx.doi.org/10.1038/s41598-023-38955-4 |
Ejemplares similares
-
Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion
por: Braimah, Imoro Z, et al.
Publicado: (2019) -
Efficacy of Modified Treat-and-Extend Aflibercept Regimen for Macular Edema Due to Branch Retinal Vein Occlusion: 1-Year Prospective Study
por: Arai, Yusuke, et al.
Publicado: (2020) -
Efficacy of Modified Treat-and-Extend Regimen of Aflibercept for Macular Edema from Branch Retinal Vein Occlusion: 2-Year Prospective Study Outcomes
por: Arai, Yusuke, et al.
Publicado: (2021) -
Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study
por: Khurana, Rahul N., et al.
Publicado: (2019) -
Subfoveal Choroidal Thickness and Treatment Outcomes of Intravitreal Aflibercept for Branch Retinal Vein Occlusion
por: Sakanishi, Yoshihito, et al.
Publicado: (2021)